Daniel Ives, Shift Bioscience
"Age is the biggest risk factor for a wide range of diseases, so if we target age, can we also prevent and even reverse these conditions?" This is the question which led Daniel Ives to found Shift Bioscience, an innovative biotech company using mitochondria to slow and potentially eliminate the effects of aging. As a young, mission driven founder, Daniel shared what he's learned in the first two years of his entrepreneurial journey, including: 🕛 How Aubrey de Grey's book "Ending Aging" influenced his career 🕦 The epigenetic aging clock, and the impact of mitochondria on biological age 🕚 Reducing the pace of aging in mice by 40-60% 🕥 The importance of remaining flexible and open-minded 🕙 How to focus on the problem and keep making progress towards it Enjoy!